| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 12/29/2004 | CN1557297A Gingko lactone powder injection and its preparation method |
| 12/29/2004 | CN1557289A Tensicor freeze-drying formulation and its making method |
| 12/29/2004 | CN1557198A Method for reducing the glycemic index of food |
| 12/29/2004 | CN1182151C Method for purifying cyclovirobuxinum D and preparation thereof |
| 12/29/2004 | CN1182134C Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for treatment of pain |
| 12/29/2004 | CN1182129C Benzopyran derivatives having leukotriene-antagonistic action |
| 12/29/2004 | CN1182127C Substituted 2-benzo [c] furanone compound, its preparing process and pharmaceutical composition containing same |
| 12/29/2004 | CN1182122C Synthesis path of Timisatem |
| 12/29/2004 | CN1182121C Compound with activity for resisting platelet aggregation and its preparation method |
| 12/29/2004 | CN1181891C The application of alpha-cyanacrylate in the preparation of medical adhesive for treating hernia and fistula |
| 12/29/2004 | CN1181890C Use of enterobacterium protein OmpA in the preparation of antigen presentation cells specified targeting medicine |
| 12/29/2004 | CN1181874C Medicine for treating acute cerebral hemorrhage and its preparing method |
| 12/29/2004 | CN1181868C Chinese medicine preparation for treating thromboangiitis obliterans |
| 12/29/2004 | CN1181867C Chinese medicine preparation for treating varicosity |
| 12/29/2004 | CN1181858C Chinese medicine composition for treating pile |
| 12/29/2004 | CN1181855C Preparing method of hypericum perforatum extract |
| 12/29/2004 | CN1181850C Chinese medicinal preparation for treating cadiovascular and cerebrovascular diseases |
| 12/29/2004 | CN1181840C Medicine for treating Alzheimer disease and cerebral ischemia encephalopathy and its preparation |
| 12/29/2004 | CN1181828C Notoginseng total saponin active element containing drop pills |
| 12/29/2004 | CN1181822C Use of 2-amino-3,4-dihydro-quinazolines for producing medicament for treating or preventing diseases caused by ischaemia conditions |
| 12/29/2004 | CA2529754A1 Medical devices and methods for regulating the tissue response to vascular closure devices |
| 12/29/2004 | CA2529288A1 Composition for lowering serum uric acid level |
| 12/29/2004 | CA2529154A1 Novel compounds that modulate ppar.gamma. type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 12/29/2004 | CA2526643A1 Use of a vegf receptor gene or gene product |
| 12/29/2004 | CA2526423A1 Inhibition of protein kinase c-mu (pkd) as a treatment for cardiac hypertrophy and heart failure |
| 12/29/2004 | CA2525847A1 Tissue modeling in embryonic stem (es) cell system |
| 12/28/2004 | US6835846 Aliphatic compounds, process for their preparation and their usage |
| 12/28/2004 | US6835837 Antiallergens; antiinflammatory agents; skin disorders; osteoporosis |
| 12/28/2004 | US6835753 Administering to the patient for inhibiting Fc receptor binding of immunoglobulin a compound selected from aromatic, heteroaromatic, cyclic, bicyclic and an amino acid derivative or salt |
| 12/28/2004 | US6835752 Carboxylic acid derivatives, processes for the preparation thereof and pharmaceutical agents comprising the same as active ingredient |
| 12/28/2004 | US6835751 Bicyclic amino acids as pharmaceutical agents |
| 12/28/2004 | US6835749 Sulfohydroxamic acids and sulfohydroxamates and their use as MEK inhibitors |
| 12/28/2004 | US6835740 Methods for treating sleep apnea and sleep induced apnea using optically pure (+) norcisapride |
| 12/28/2004 | US6835738 Phenylalanine enamide derivatives |
| 12/28/2004 | US6835737 Quinoline inhibitors of cGMP phosphodiesterase |
| 12/28/2004 | US6835731 Chemokine receptor binding heterocyclic compounds |
| 12/28/2004 | US6835716 Bactericides, antiprotozoa agents |
| 12/28/2004 | US6835715 Mammalian dihydroouabain-like factor and therapeutic compositions |
| 12/28/2004 | US6835711 Use of poly-Glu,Tyr for neuroprotective therapy |
| 12/28/2004 | US6835564 Human endothelin converting enzyme-like proteins and polynucleotides encoding the same |
| 12/28/2004 | US6835546 Drosophila G protein coupled receptors, nucleic acids, and methods related to the same |
| 12/28/2004 | US6835401 Method of treating diseases caused by over-production of free-radicals |
| 12/28/2004 | US6835372 Mixtures of di-(tri)peptides and drugs such as cyclosporin used as aerosols; drug delivery |
| 12/28/2004 | CA2268922C Methods of treating or preventing cardiac arrhythmia |
| 12/28/2004 | CA2226039C Pyridylfuran and pyridylthiophene compounds |
| 12/28/2004 | CA2161443C Large potassium bicarbonate crystals and process for the preparation thereof |
| 12/28/2004 | CA2072874C Polypeptides having human dopaminergic receptor activity, nucleic acids coding for said polypeptides and uses thereof for screening active substances on said polypeptides |
| 12/23/2004 | WO2004111057A1 Thienopyrimidine derivatives as potassium channel inhibitors |
| 12/23/2004 | WO2004111048A1 3-(guanidinocarbonyl)heterocycle derivatives, preparation process and intermediates of this process, their use as medicaments, and pharmaceutical compositions including them |
| 12/23/2004 | WO2004111038A1 5,6-bis (4-chlorophenyl)-n-piperidin1-yl-3-(piperidin-1-yl-carbonyl)pyrazine-2-carboxamide |
| 12/23/2004 | WO2004111037A1 Cyclic tertiary amine compound |
| 12/23/2004 | WO2004111033A1 2-substitued 5, 6-diaryl-pyrazine derivatives as cb1 modulator. |
| 12/23/2004 | WO2004111020A1 Aniline derivatives |
| 12/23/2004 | WO2004110559A1 Adjustable, non-electric liquid air-freshener device |
| 12/23/2004 | WO2004110489A1 MEDICINAL COMPOSITION FOR PREVENTING OR TREATING Th1 TYPE IMMUNOLOGICAL DISEASE |
| 12/23/2004 | WO2004110471A1 Preventive or remedy for disease associated with apoptosis |
| 12/23/2004 | WO2004110454A1 COMPOSITION FOR TREATMENT FOR OR PREVENTION OF DISEASE NECESSITATING ADMINISTRATION OF ADENOSINE A2a RECEPTOR AGONIST |
| 12/23/2004 | WO2004110448A1 Medicinal composition containing benidipine hydrochloride |
| 12/23/2004 | WO2004110433A1 Pyrrolidin-1, 2- dicarboxylic acid- 1- [(4- ethinyl- phenyl) - amid]- 2- [(phenyl)- amid] derivative as inhibitors of coagulation factor xa and viia for the treatment of thrombosis |
| 12/23/2004 | WO2004110432A1 Enalapril-nitroxyderivatives derivatives and related compounds as ace inhibitors for the treatment of cardiovascular diseases |
| 12/23/2004 | WO2004110427A1 Preventing atrial fibrillation (af) with the use of statin drugs |
| 12/23/2004 | WO2004110379A2 A1 adenosine receptor antagonists |
| 12/23/2004 | WO2004110344A2 New azetidine compounds |
| 12/23/2004 | WO2004093852A3 Use of steroid derivatives for the treatment of angiotensin ii related disease e.g. cardiovascular and proliferative disorders |
| 12/23/2004 | WO2004064836A3 Treatment of diseases with alpha-7 nach receptor full agonists |
| 12/23/2004 | WO2004049095A3 Betaine and salicylic acid compositions |
| 12/23/2004 | WO2004045563A3 Method of treatment of myocardial infarction |
| 12/23/2004 | WO2004022123A8 Coated stent |
| 12/23/2004 | WO2003082198A3 Methods of treatment with lxr modulators |
| 12/23/2004 | US20040260268 Drug/drug delivery systems for the prevention and treatment of vascular disease |
| 12/23/2004 | US20040260094 such as 8-amino-4-benzylamino-quinoline-3-carboxylic acid ethyl ester; for treatment of Alzheimer's disease, Huntington's disease, Parkinson's disease, AIDS, stroke, ischemia, traumatic brain injury, spinal cord injury or osteoarthritis |
| 12/23/2004 | US20040259953 Use of the (1S,2R) enantiomer of milnacipran for the preparation of a drug |
| 12/23/2004 | US20040259949 Aminolevulinulic acid/5-/ and derivatives for healing wounds with heat and photosensitizers for ulcers |
| 12/23/2004 | US20040259945 Tetrapropylammonium tetrathiomolybdate and related compounds for anti-angiogenic therapies |
| 12/23/2004 | US20040259932 Method and compound to reduce the incidence of diabetes in a subject with chronic heart failure |
| 12/23/2004 | US20040259930 Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 12/23/2004 | US20040259928 Enzyme inhibitors for antidiabetic agents, antitumor disorders, treatment of skin disorters, anticancer agents and cognitive activators for Alzheimers disease treatment |
| 12/23/2004 | US20040259927 Compounds for treatment of sleep apnea, respiratory system disorders or kidney failure |
| 12/23/2004 | US20040259925 Pharmaceutical compositions and methds for the prevention or treatment of cardiovascular, cardiopulmonary, pulmonary or renal diseases |
| 12/23/2004 | US20040259924 A metabolite of repinotan hydrochloride that have high affinity for binding to the serotonin receptors of the 5-HT1A type; treating stroke or skull-brain trauma; anxiolytic agents; antidepressants; sexual, sleep and food disorders |
| 12/23/2004 | US20040259912 N-(4-benzhydryloxy-3-isobutyrylphenyl)-N'-(3,4-dimethoxyphenyl)urea for example; vanilloid receptor agonists; use as analgesic and or for treating urinary frequency and/or urinary incontinence |
| 12/23/2004 | US20040259907 4-oxo-4,7-dihydrofuro[2,3-b]pyridine-5-carboxamide antiviral agents |
| 12/23/2004 | US20040259897 transplant rejection, rheumatoid arthritis, osteoarthritis, diabetes, asthma, inflammatory bowel disease, and chronic obstructive pulmonary disease; inhibitors of Lymphocyte Function-associated Antigen 1 (LFA-1)/intercellular adhesion molecule (ICAM); 2,4-dioxo-1,3,7-triazaspiro[4.4]nonanes |
| 12/23/2004 | US20040259893 Use of tyrosine kinase inhibitions for treating allergic diseases |
| 12/23/2004 | US20040259890 trans-3'-oxo-N-(trans-4-phenylcyclohexyl)-spiro[cyclohexane-1,1'(3'H)-isobenzofuran]-4-carboxamide e.g.; neuropeptide Y receptor antagonists for treatment of bulimia, obesity or diabetes for example |
| 12/23/2004 | US20040259889 Vasconstriction ; administering adenosine receptor antagonist |
| 12/23/2004 | US20040259888 Antiischemic agents; cardiovascular disorders; analgesics; neurodegenerative disease |
| 12/23/2004 | US20040259886 Compositions and methods for treating osteoporosis and lowering cholesterol |
| 12/23/2004 | US20040259879 Antiarthritic agents; colon cancer, neurodegenerative agents |
| 12/23/2004 | US20040259876 Bicyclic compound, production and use thereof |
| 12/23/2004 | US20040259875 Incontinence; overactive bladder; neuropathic pain; neuralgia; analgesics; stroke; antiarthritic agents; antiinflammatory agents |
| 12/23/2004 | US20040259871 Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses |
| 12/23/2004 | US20040259869 Cycloalkyl alkanoic acids as integrin receptor antagonists |
| 12/23/2004 | US20040259865 Laxative; adenosine receptor antagonist |
| 12/23/2004 | US20040259864 Substituted pyrimidinone derivatives as ligands of integrin receptors |
| 12/23/2004 | US20040259863 Type 4 phosphodiesterase inhibitors and uses thereof |
| 12/23/2004 | US20040259861 Antiischemic agents |
| 12/23/2004 | US20040259858 such as 3-(2-methyl-4-pyrrolidin-1-yl-quinolin-7-yl-methoxy)-benzonitrile; neuropeptide y receptor antagonists; for treatment or prevention of arthritis, cardiovascular diseases, diabetes, renal failure, eating disorders and obesity |
| 12/23/2004 | US20040259857 Hypotensive agents; dysmenorrhea; antiischemic agents; liver cirrhosis; kidney diseases; liver disorders; strokes; cantral nervous system disorders |
| 12/23/2004 | US20040259842 Anticoagulants ; antiischemic agents; autoimmune disease; antihistamines; antiallergens; antihistamines; brain disorders; kidney disease; pancreatitis; Alzheimer's disease |